Jack W. Fisher
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jack W. Fisher.
Tetrahedron Letters | 1987
Louis Nickolaus Jungheim; Sandra Kay Sigmund; Jack W. Fisher
Abstract Several bicyclic pyrazolidinones were synthesized as γ-lactam analogs of the β-lactam antibiotics. Two of these compounds exhibited in vitro antibacterial activity, and thus constitute a new class of antibacterial agents.
Tetrahedron Letters | 1989
Christina Bodurow; B. D. Boyer; John Brennan; C. A. Bunnell; J. E. Burks; Michael A. Carr; Christopher W. Doecke; T. M. Eckrich; Jack W. Fisher; John P. Gardner; B. J. Graves; P. Hines; Richard Charles Hoying; Billy Grinnell Jackson; Michael Dean Kinnick; C. D. Kochert; J. S. Lewis; W. D. Luke; Larry L. Moore; J. M. Jun. Morin; R. L. Nist; D. E. Prather; D. L. Sparks; William Charles Vladuchick
Abstract An enantioselective synthesis of the new, orally absorbable, totally synthetic β-lactam antibiotic, loracarbef (LY163892/KT3777) is described.
Tetrahedron Letters | 1994
Jack W. Fisher; Kristina L Trinkle
Abstract Lithium iodide promotes ester dealkylation in compounds containing an amide carbonyl in the γ-position to the ester carbonyl, as is found in N-acyl amino acid esters. Activation of the ester carbonyl via lithium ion coordination is facilitated by aprotic non-polar solvents such as THF and EtOAc. This process is not limited to methyl esters but readily dealkylates benzyl, PMB, PNB, and t-butyl esters and is especially suitable for use with β-lactam esters because of the mild conditions.
Tetrahedron | 2000
Billy Grinnell Jackson; Steve W Pedersen; Jack W. Fisher; Jerry Wayne Misner; John P. Gardner; Michael A. Staszak; Christopher W. Doecke; John Robert Rizzo; James Abraham Aikins; Eugene Farkas; Kristina L Trinkle; Jeffrey T. Vicenzi; Matt R. Reinhard; Eugene Paul Kroeff; Chris A Higginbotham; Robert James Gazak; Tony Y. Zhang
Abstract Serine hydroxymethyltransferase (SHMT) derived from recombinant E. coli was found to be able to catalyze the condensation between glycine and 4-pentenaldehyde, affording enantiopure l -erythro-2-amino-3-hydroxy-6-heptenoic acid (AHHA) in high yield and throughput. Conversion of this chiral intermediate of biosynthetic origin to the oral carbacephalosporin antibiotic loracarbef (Lorabid®) via β-lactam forming reactions and subsequent Dieckmann cyclization was achieved.
Tetrahedron Letters | 1993
Jack W. Fisher; James M. Dunigan; Lowell D. Hatfield; Richard Charles Hoying; James E. Ray; Kristina Lynn Thomas
Abstract A new technique for cleaving N-substituted 4-phenyl-2-oxazolidinones is described. Thus reaction of a 7-[4-phenyl-2-oxazolidinone]-carbacephem with TMSI and HMDS in acetonitrile, followed by DABCO, then aqueous hydrochloric acid gives the carbacephem nucleus, carbon dioxide, and acetophenone. This method allows a more versatile use of 4-phenyl-2-oxazolidinone as a chiral auxiliary and N-protective group in the synthesis of carbacephems.
Tetrahedron Letters | 2003
Jerry Wayne Misner; Jack W. Fisher; John P. Gardner; Steve W Pedersen; Kristina L Trinkle; Billy Grinnell Jackson; Tony Y. Zhang
The nucleus of the carbacephem antibiotic loracarbef was synthesized in a highly efficient and enantioselective fashion from 2S,3S-2-amino-3-hydroxy-6-heptenoic acid (AHHA), which was derived from enzyme-catalyzed condensation of glycine and 4-pentenaldehyde. The bicyclic framework of this compound was established through sequential Mitsunobu reaction and aldol condensations.
Tetrahedron Letters | 1970
Lowell D. Hatfield; Jack W. Fisher; F.L. Jose; Robin D. G. Cooper
Archive | 1980
Jack W. Fisher
Journal of Pharmaceutical Sciences | 1986
Joseph M. Indelicato; Jack W. Fisher; Carol Elaine Pasini
Archive | 1980
Lowell D. Hatfield; Larry C. Blaszczak; Jack W. Fisher